Note: Ingredients listed on restricted chemical lists
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
*
EC/CAS
232-679-6/9005-25-8
Name of the chemical
Starch
Concentration
*
EC/CAS
200-559-2/63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
#3_T_CONCENTRATION
General Information
Version
1.3
Revision date
2013-08-26
Product name
Neurontin
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product used as anticonvulsant
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance Blue , orange or beige capsules
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term Dust may cause irritation (based on components) . The active ingredient is not acutely toxic. Known Clinical Effects Adverse effects associated with therapeutic use include dizziness, tiredness, swelling, and nausea.
EU Classification
EU Indication of danger Not classified Australian Hazard Classification (NOHSC): Note Non-Hazardous Substance. Non-Dangerous Goods. This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
